title: Haematological cancer: PomCyDex - a lower-cost option in refractory myeloma?
authors.forename: David
authors.initials: D
authors.lastname: Killock
mesh_terms: D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D013792:Thalidomide / Q000627:therapeutic use
chemical_list: D013792:Thalidomide